Stephen J. Marx
#126,401
Most Influential Person Now
Stephen J. Marx's AcademicInfluence.com Rankings
Stephen J. Marxphilosophy Degrees
Philosophy
#5942
World Rank
#8880
Historical Rank
Logic
#3145
World Rank
#4262
Historical Rank
Stephen J. Marxbiology Degrees
Biology
#8030
World Rank
#11041
Historical Rank
Endocrinology
#85
World Rank
#96
Historical Rank
Genetics
#786
World Rank
#878
Historical Rank
Molecular Biology
#981
World Rank
#1005
Historical Rank
Download Badge
Philosophy Biology
Stephen J. Marx's Degrees
- Doctorate Medicine Harvard University
Why Is Stephen J. Marx Influential?
(Suggest an Edit or Addition)Stephen J. Marx's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Positional cloning of the gene for multiple endocrine neoplasia-type 1. (1997) (1906)
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 (2001) (1576)
- Guidelines for diagnosis and therapy of MEN type 1 and type 2. (2001) (1038)
- Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism (1993) (1003)
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome (2002) (658)
- Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription (1999) (627)
- NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. (2010) (489)
- Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. (1997) (461)
- Menin, the product of the MEN1 gene, is a nuclear protein. (1998) (435)
- A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. (2001) (434)
- Hyperparathyroid and hypoparathyroid disorders. (2000) (423)
- Somatic mutation of the MEN1 gene in parathyroid tumours (1997) (401)
- The Hypocalciuric or Benign Variant of Familial Hypercalcemia: Clinical and Biochemical Features in Fifteen Kindreds (1981) (371)
- Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics (1998) (357)
- Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. (1997) (305)
- Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. (1983) (287)
- Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. (1997) (281)
- Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. (2009) (281)
- Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. (1994) (260)
- Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. (2016) (258)
- Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. (1997) (238)
- Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. (1980) (237)
- Mutations of the MEN1 tumor suppressor gene in pituitary tumors. (1997) (235)
- Familial Isolated Hyperparathyroidism: Clinical and Genetic Characteristics of 36 Kindreds (2002) (234)
- A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. (1996) (232)
- Of Mice and MEN1: Insulinomas in a Conditional Mouse Knockout (2003) (229)
- The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation (2001) (223)
- Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 Tumorigenesis (2006) (211)
- Calcitonin Receptors of Kidney and Bone (1972) (201)
- Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. (2009) (199)
- Localisation of mesenchymal tumours by somatostatin receptor imaging (2002) (196)
- Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. (1983) (188)
- Multiple endocrine neoplasia type 1: new clinical and basic findings (2001) (187)
- Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. (1998) (176)
- Molecular genetics of multiple endocrine neoplasia types 1 and 2 (2005) (172)
- Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. (1999) (171)
- An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. (1982) (170)
- Familial multiple endocrine neoplasia type I: a new look at pathophysiology. (1987) (167)
- Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. (1997) (165)
- Molecular genetics of multiple endocrine neoplasia types 1 and 2 (2005) (165)
- Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression (2005) (162)
- FGF-23 is elevated by chronic hyperphosphatemia. (2004) (159)
- Calcium-regulated parathyroid hormone release in primary hyperparathyroidism: studies in vitro with dispersed parathyroid cells. (1979) (150)
- Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. (2004) (148)
- Molecular Pathology of the MEN1 Gene (2004) (148)
- Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. (1996) (137)
- Hyperparathyroidism in hereditary syndromes: special expressions and special managements. (2002) (133)
- Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. (2000) (132)
- Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes. (1985) (131)
- Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. (1995) (131)
- Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter (2003) (130)
- Preparation and characterization of a hormone-responsive renal plasma membrane fraction. (1972) (129)
- Menin molecular interactions: insights into normal functions and tumorigenesis. (2005) (129)
- Prospective Study of Surgery for Primary Hyperparathyroidism (HPT) in Multiple Endocrine Neoplasia-Type 1 and Zollinger-Ellison Syndrome: Long-Term Outcome of a More Virulent Form of HPT (2008) (129)
- The 32-Kilodalton Subunit of Replication Protein A Interacts with Menin, the Product of the MEN1 Tumor Suppressor Gene (2003) (128)
- Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. (1993) (128)
- Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. (1999) (128)
- Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. (1997) (126)
- A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. (1997) (126)
- Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. (1978) (126)
- Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. (1986) (126)
- Dispersed cells prepared from human parathyroid glands: distinct calcium sensitivity of adenomas vs. primary hyperplasia. (1978) (124)
- A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. (1981) (122)
- Common ancestral mutations in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland (1998) (121)
- Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. (1980) (121)
- A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. (1978) (121)
- Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. (1987) (119)
- The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. (2001) (117)
- Family studies in patients with primary parathyroid hyperplasia. (1977) (115)
- The parathyroid glands in familial hypocalciuric hypercalcemia. (1981) (115)
- Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. (1981) (113)
- Stable overexpression of MEN1 suppresses tumorigenicity of RAS (1999) (109)
- Allelic loss from chromosome 11 in parathyroid tumors. (1992) (107)
- Bidirectional transcriptional activity of PGK‐neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice (2001) (106)
- MEN1 gene analysis in sporadic adrenocortical neoplasms. (1999) (105)
- Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. (1985) (103)
- A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1,25-dihydroxyvitamin D3. (1990) (103)
- Familial hypocalciuric hypercalcemia. (1980) (103)
- GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. (2016) (101)
- Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts. (1983) (101)
- Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas. (2000) (101)
- The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization. (2011) (99)
- Immunocytology with microwave-fixed fibroblasts shows 1 alpha,25- dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors (1990) (99)
- Calcitonin receptors on cultured human lymphocytes. (1974) (98)
- Comparative genomic hybridization analysis of human parathyroid tumors. (1998) (98)
- Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. (2003) (98)
- Familial hypocalciuric hypercalcemia: the relation to primary parathyroid hyperplasia. (1982) (97)
- Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. (1993) (96)
- Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. (1981) (93)
- A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase. (2015) (91)
- Multiple Endocrine Neoplasia Type I: Assessment of Laboratory Tests to Screen for the Gene in a Large Kindred (1986) (91)
- Renal receptors for calcitonin. Binding and degradation of hormone. (1973) (91)
- Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. (1998) (89)
- Aspiration of enlarged parathyroid glands for parathyroid hormone assay. (1983) (89)
- Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. (2003) (87)
- Hereditary hormone excess: genes, molecular pathways, and syndromes. (2005) (84)
- The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. (2007) (84)
- Inhibitory effects of tumor necrosis factor-α and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8) (1989) (80)
- Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. (1983) (79)
- MEN1 gene mutation analysis of high‐grade neuroendocrine lung carcinoma (2000) (79)
- Genetic abnormalities in sporadic parathyroid adenomas. (1990) (78)
- Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism. (1995) (77)
- Neonatal primary hyperparathyroidism with autosomal dominant inheritance. (1977) (77)
- Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism (1995) (75)
- Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism. (1979) (74)
- Vitamin D3--resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors. (1984) (74)
- Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin. (1981) (73)
- Primary hyperparathyroidism. Preoperative tumor localization and differentiation between adenoma and hyperplasia. (1972) (72)
- Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. (2000) (71)
- Reoperative parathyroid surgery for persistent hyperparathyroidism. (1978) (71)
- Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds (1993) (70)
- Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. (2001) (70)
- Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. (1990) (70)
- Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. (1992) (70)
- Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia. (2005) (70)
- Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts. (1985) (69)
- Thyroid dysfunction in pseudohypoparathyroidism. (1971) (68)
- PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex (2002) (67)
- Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. (2004) (66)
- Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. (1990) (65)
- Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. (1986) (65)
- Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. (2009) (65)
- Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. (1997) (65)
- Results of heterotopic parathyroid autotransplantation: a 13-year experience. (1999) (64)
- Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1 (1991) (64)
- Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3 or only vitamin D2. (1989) (64)
- Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. (2015) (63)
- Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. (1988) (63)
- Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. (1986) (61)
- Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1. (2001) (60)
- Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region (1997) (60)
- Results of reoperation for persistent and recurrent hyperparathyroidism. (1981) (59)
- Hyperparathyroidism-jaw tumor syndrome: Results of operative management. (2014) (59)
- Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperparathyroidism. (1993) (59)
- Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts. (1988) (57)
- Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1 (2004) (57)
- Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors. (1999) (56)
- Localization of parathyroid adenomas in patients who have undergone surgery. Part II. Invasive procedures. (1987) (56)
- Computed Tomography for Parathyroid Localization (1977) (56)
- Hereditary resistance to 1,25-dihydroxyvitamin D. (1984) (56)
- Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. (1994) (56)
- Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation. (2007) (53)
- Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. (1980) (53)
- Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. (1978) (52)
- Autotransplantation of Cryopreserved Parathyroid Tissue in Man (1979) (52)
- Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors. (2017) (50)
- Parathyroid adenomas in the aortopulmonary window. (1996) (50)
- Reoperation for parathyroid adenoma: a contemporary experience. (2009) (49)
- The MEN1 Gene and Pituitary Tumours (2009) (48)
- The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. (2008) (48)
- Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism. (1994) (47)
- Assessment of techniques for preoperative parathyroid gland localization in patients undergoing reoperation for hyperparathyroidism. (1982) (47)
- Cloned endothelial cells from fetal bovine bone. (1989) (47)
- Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation. (1986) (46)
- Recurrent hyperparathyroidism from an autotransplanted parathyroid adenoma. (1978) (46)
- Cushing’s syndrome in multiple endocrine neoplasia type 1 (2012) (46)
- Angiographic ablation of parathyroid adenomas: lessons from a 10-year experience. (1987) (46)
- Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. (1988) (46)
- Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. (1986) (46)
- Characterization of a MEN1 ortholog from Drosophila melanogaster. (2001) (44)
- A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13. (1997) (44)
- Rapid accumulation of cyclic GMP near activated vitamin D receptors. (1991) (44)
- Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain (2003) (44)
- The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3 (2008) (44)
- Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy. (1986) (43)
- Structure, synthesis, and mechanism of action of parathyroid hormone. (1972) (43)
- Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families (1998) (42)
- Calciferols: actions and deficiencies in action. (1983) (41)
- Deferred parathyroid autografts with cryopreserved tissue after reoperative parathyroid surgery. (1982) (41)
- Angiographic ablation of parathyroid adenomas. (1979) (40)
- Treatment of hyperparathyroidism by percutaneous embolization of a mediastinal adenoma. (1975) (39)
- Use of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism. (1994) (39)
- Isolation, characterization, expression and functional analysis of the zebrafish ortholog of MEN1 (2000) (38)
- Binding of radioiodinated bovine parathyroid hormone-(1-84) to canine renal cortical membranes. (1983) (38)
- Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. (1997) (37)
- Familial hyperparathyroidism. Mild hypercalcemia in at least nine members of a kindred. (1973) (36)
- Locally recurrent parathyroid neoplasms as a cause for recurrent and persistent primary hyperparathyroidism. (1991) (36)
- Deficiency of hormone receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyroidism. (1982) (36)
- Persistent Primary Hyperparathyroidism Caused by Adenomas Identified in Pharyngeal or Adjacent Structures (2003) (36)
- Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. (1989) (36)
- Parathyroid tumor development involves deregulation of homeobox genes. (2008) (35)
- The gene for multiple endocrine neoplasia type 1: recent findings. (1999) (35)
- Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase. (1975) (34)
- The localization of abnormal mediastinal parathyroid glands. (1975) (33)
- Identification and characterization of JunD missense mutants that lack menin binding (2000) (33)
- Hyperparathyroidism--a reversible cause of cimetidine-resistant gastric hypersecretion. (1979) (33)
- Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements. (2017) (33)
- Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism. (2002) (33)
- Hyperparathyroid genes: sequences reveal answers and questions. (2011) (33)
- Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism. (1982) (31)
- Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone. (1983) (31)
- Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure (2016) (30)
- Benign breast dysplasia causing hypercalcemia. (1977) (30)
- Plasma chromogranin-A in primary hyperparathyroidism. (1989) (30)
- Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism. (2002) (30)
- Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia. (1999) (30)
- Rapid effects of insulin on cyclic GMP location in an intact protozoan (1992) (30)
- Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gsα, and Gi2α genes in isolated familial acromegaly (2001) (30)
- The blood supply of mediastinal parathyroid adenomas. (1977) (29)
- Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism (2018) (29)
- The detection of mediastinal parathyroid glands by computed tomography, selective arteriography, and venous sampling: an analysis of 17 cases. (1981) (28)
- Intrathyroidal parathyroid adenoma or hyperplasia. An occasionally overlooked cause of surgical failure in primary hyperparathyroidism. (1975) (28)
- Undescended parathyroid adenoma: An important etiology for failed operations for primary hyperparathyroidism (1990) (28)
- Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. (1980) (28)
- Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial (2015) (28)
- Preoperative Localizing Studies for Initial Parathyroidectomy in MEN1 Syndrome: Is There Any Benefit? (2012) (27)
- Recent Topics Around Multiple Endocrine Neoplasia Type 1 (2018) (27)
- Calcimimetic Use in Familial Hypocalciuric Hypercalcemia—A Perspective in Endocrinology (2017) (27)
- 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1. (1998) (27)
- Hyperfunctioning cystic parathyroid glands: CT and sonographic findings. (1984) (26)
- Human parathyroid autografts: comparison of function in vivo and in vitro. (1979) (26)
- Utility of Intraoperative Parathyroid Hormone Monitoring in Patients with Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism Undergoing Initial Parathyroidectomy (2013) (26)
- Parathyroid venous sampling. (1972) (24)
- Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective (2018) (24)
- Intraoperative measurements of urinary cyclic AMP to guide surgery for primary hyperparathyroidism. (1980) (24)
- Aggressive pituitary tumors in MEN1: do they refute the two-hit model of tumorigenesis? (2002) (24)
- The effect of short term lithium administration on suppressibility of parathyroid hormone secretion by calcium in vivo. (1984) (24)
- Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene (1999) (24)
- Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability (2004) (24)
- Neonatal Severe Hyperparathyroidism: Novel Insights from Calcium, PTH, and the CASR Gene. (2019) (23)
- Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism (2017) (23)
- Demonstration of parathyroid adenomas by retrograde thyroid venography. (1972) (23)
- Urinary cAMP excretion during surgery: an index of successful parathyroidectomy in patients with primary hyperparathyroidism. (1978) (23)
- Familial Hyperparathyroidism – Disorders of Growth and Secretion in Hormone-Secretory Tissue (2017) (22)
- New Concepts About Familial Isolated Hyperparathyroidism. (2019) (22)
- Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure (2018) (22)
- Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. (2013) (22)
- Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma. (1978) (22)
- Radioimmunoassay for the middle region of human parathyroid hormone: comparison of two radioiodinated synthetic peptides. (1985) (22)
- Low affinity of the receptor for 1α, 25‐dihydroxyvitamin D3 in the marmoset, a new world monkey (1985) (22)
- Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism (2016) (21)
- CLINICAL ENDOCRINOLOGY & METABOLISM (1992) (21)
- Differential diagnosis of brown tumor vs. cystic osteitis by arteriography and computed tomography. (1979) (20)
- Pseudohypoparathyroidism: the molecular basis for hormone resistance--a retrospective. (1982) (20)
- The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism. (1997) (20)
- Primary Hyperparathyroidism in Familial Multiple Endocrine Neoplasia Type I. Long-Term Follow-Up of Serum Calcium Levels After Parathyroidectomy (1985) (20)
- Resistance to Vitamin D (1984) (19)
- Preoperative Localization of Hyperfunctioning Parathyroid Tissue: Radioimmunoassay of Parathyroid Hormone in Plasma from Selectively Catheterized Thyroid Veins (1973) (19)
- Mouse Embryo Fibroblasts Lacking the Tumor Suppressor Menin Show Altered Expression of Extracellular Matrix Protein Genes (2007) (18)
- The molecular basis for resistance to 1,25-dihydroxyvitamin D: studies in cells cultured from patients with hereditary hypocalcemic 1,25(OH)2D3-resistant rickets. (1986) (18)
- Intraoperative ultrasound and reoperative parathyroid surgery: An initial evaluation (1986) (17)
- Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8). (1989) (17)
- Computerized technetium/thallium scans and parathyroid reoperation. (1985) (17)
- Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1. (1988) (17)
- Overexpression of the human vitamin D3 receptor in mammalian cells using recombinant adenovirus vectors. (1991) (17)
- Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium. (2015) (17)
- Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II). (1986) (17)
- Chapter 76. Familial Hyperparathyroidism (Including MEN, FHH, and HPT‐JT) (2009) (16)
- Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. (2018) (16)
- Parathymic parathyroid: CT, US, and angiographic findings. (1985) (16)
- Radiographic findings in recurrent parathyroid carcinoma. (1982) (16)
- HORMONES AND OTHER FACTORS REGULATING CALCIUM METABOLISM (1971) (15)
- The effect of the bicarbonate anion on serum ionized calcium concentration in vitro. (1984) (15)
- PARATHYROID FUNCTION AFTER PARATHYROIDECTOMY: EVALUATION BY MEASUREMENT OF URINARY cAMP (1981) (15)
- Dual effects of calcitonin and calcitonin gene-related peptide on intracellular cyclic 3',5'-monophosphate in a human breast cancer cell line. (1988) (15)
- ???Familial Multiple Endocrine Adenoma???Peptic Ulcer Complex???: A Classic in Medicine (1991) (14)
- International Workshop on Multiple Endocrine Neoplasia (MEN2004) (2004) (14)
- Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly. (2001) (14)
- Familial multiple endocrine neoplasia type I. (1988) (14)
- Genetic interactions between Drosophila melanogaster menin and Jun/Fos. (2006) (14)
- Production and purification of human menin from Drosophila melanogaster S2 cells using stirred tank reactor (2001) (13)
- 11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes. (1998) (13)
- Work in progress: abnormal parathyroid glands. Comparison of nonselective arterial digital arteriography, selective parathyroid arteriography, and venous digital arteriography as methods of detection. (1983) (13)
- Gland Size Is Associated With Changes in Gene Expression Profiles in Sporadic Parathyroid Adenomas (2004) (13)
- Familial Hypocalciuric Hypercalcemia Versus Typical Primary Hyperparathyroidism (1978) (13)
- Germline AIP, MEN1, PRKAR1A, CDKN1B (p27Kip1) and CDKN2C (p18INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features (2008) (13)
- ABO(H) cell surface antigens in parathyroid adenoma and hyperplasia. (1981) (13)
- Children with MEN1 gene mutations may present first (and at a young age) with Cushing disease (2018) (13)
- Dideoxyfingerprinting (ddF) analysis of the type X collagen gene (COL10A1) and identification of a novel mutation (S671P) in a kindred with Schmid metaphyseal chondrodysplasia. (1996) (12)
- High cervical intravagal hypercellular parathyroid gland as the etiology of severe persistent primary hyperparathyroidism. (1995) (12)
- Prospective analysis of intraoperative and postoperative urinary cyclic adenosine 3',5'-monophosphate levels to predict outcome of patients undergoing reoperations for primary hyperparathyroidism. (1988) (12)
- Tissue‐selective 1,25‐dihydroxyvitamin D3 resistance: Novel applications of calciferols (1988) (12)
- Familial Primary Hyperparathyroidism (Including MEN, FHH, and HPT‐JT) (2013) (12)
- Multiple endocrine neoplasias in the era of translational medicine. (2005) (11)
- The use of high-resolution ultrasound to locate parathyroid tumors during reoperations for primary hyperparathyroidism (1987) (11)
- Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing. (2018) (11)
- Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma. (2013) (11)
- Circumscribing or periadenomal vessel: a helpful angiographic finding in certain islet cell and parathyroid adenomas. (1981) (11)
- Clinical review 109: Contrasting paradigms for hereditary hyperfunction of endocrine cells. (1999) (11)
- Hypocalciuria and abnormalities in mineral and skeletal homeostasis in patients with celiac sprue without intestinal symptoms (1997) (10)
- Hyperplasia in glands with hormone excess. (2016) (10)
- Clinical Endocrinology 6 Metabolism Editor-in-chief: Delbert A. Fisher (10)
- Parathyroid imaging after intraarterial injections of [75Se]selenomethionine. (1981) (10)
- Long-term remission of disseminated parathyroid cancer following immunotherapy (2019) (10)
- Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor. (2012) (10)
- Hypocalcemic stimulation and nonselective venous sampling for localizing parathyroid adenomas: work in progress. (1998) (9)
- Embolization of a mediastinal parathyroid adenoma. (1974) (9)
- Heterogeneous hormonal disorder in pseudohypoparathyroidism. (1977) (9)
- The role of guanine nucleotides in regulation of adenylate cyclase activity. (1981) (9)
- Diagnosis of Asymptomatic Primary Hyperparathyroidism : Proceedings of the Society (2009) (8)
- Multiplicity of hormone-secreting tumors: common themes about cause, expression, and management. (2013) (8)
- Failure of ablation of a mediastinal parathyroid adenoma by repeated contrast staining. (1981) (8)
- Preoperative localization of abnormal parathyroid: neck massage versus arteriography and selective venous sampling. (1978) (8)
- Detection of mediastinal parathyroid glands by nonselective digital arteriography. (1984) (8)
- A pulsed-field gel electrophoresis (PFGE) map of twelve loci on chromosome 11q11-q13. (1993) (7)
- Ultrasonic parathyroid localisation in previously operated patients. (1984) (7)
- Dermatoglyphic and radiographic findings in a mother and daughter with pseudohypoparathyroidism (1978) (7)
- New insights into primary hyperparathyroidism. (1984) (7)
- FBP1 Is an Interacting Partner of Menin (2014) (7)
- CHAPTER 35 – Multiple Endocrine Neoplasia Type 1 (2001) (7)
- Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism (1991) (6)
- Management of primary parathyroid hyperplasia. (1976) (6)
- Arteriographic localization of parathyroid adenoma in the presence of lingual thyroid. (1981) (6)
- CHAPTER 41 – Multiple Endocrine Neoplasia (2011) (6)
- BRIEF REPORT The Parathyroid/Pituitary Variant of Multiple Endocrine Neoplasia Type 1 Usually Has Causes Other than p27 Kip1 Mutations (2007) (6)
- VITAMIN D DEPENDENT RICKETS TYPE 11 (DD11) WITH ALO PECIA. TREATMENT WITH MEGA DOSES OF 1, 25(OH)2 D3 OVERCOMES AFFINITY DEFECT IN RECEPTOR FOR 1,25(OH)2 D (1984) (5)
- A patient with MEN1 typical features and MEN2-like features. (2016) (5)
- Uncoupling of secretion from growth in some hormone secretory tissues. (2014) (5)
- Urinary cyclic 3',5'-adenosine monophosphate (cAMP): an index of the action of parathyroid hormone on the kidney. (1980) (5)
- Familial multiple endocrine neoplasia type 1 Mutation of a tumor suppressor gene (1989) (5)
- Discussion section I (1991) (5)
- Hypoparathyroidism: a possible cause of rickets. (1985) (5)
- Ongoing protein synthesis needed for 1,25‐(OH)2D3‐mediated rapid increase of cyclic GMP in human skin fibroblasts (1988) (5)
- 9 – Familial hypocalciuric hypercalcemia (1982) (5)
- Scleral calcifications in hyperparathyroidism: demonstration by computed tomography. (1977) (4)
- Occurrence of multiple endocrine neoplasia type 1 (MEN-1) gene mutations in patients with zollinger-ellison syndrome (ZES) (1998) (4)
- Genetic defects in primary hyperparathyroidism. (1988) (4)
- Multiple angiofibromas and collagenomas in a 45-year-old man with recurrent nephrolithiasis, fatigue, and vision loss. (2009) (4)
- Parathyroid gland morphology in nonparathyroid hormone-mediated hypercalcemia (1985) (4)
- Calcium sensing comes full circle (1995) (4)
- High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy (2019) (4)
- Fibroblast Growth Factor–like Autoantibodies in Plasma from Patients with Multiple Endocrine Neoplasia Type 1 and Prolactinoma (1997) (4)
- Parathyroid aspiration directed by angiography: an alternative to venous sampling. (1984) (4)
- In vitro studies of parathyroid hormone release: effect of cimetidine. (1982) (4)
- Scleral Calcifications in Hyperparathyroidism: Demonstration by Computed Tomography (1977) (4)
- Questions and Controversies About Parathyroid Pathophysiology in Children With Multiple Endocrine Neoplasia Type 1 (2018) (3)
- [19] Adenylate cyclase from kidney and bone (1974) (3)
- RECEPTOR MEDIATED RAPID ACTIONS OF STEROID HORMONES: cGMP ACCUMULATION AND REORGANIZATION OF RECEPTORS (1991) (3)
- 12 Parathyroid hormone and vitamin D receptors (1983) (3)
- Total body retention of orally administered 47-calcium in primary hyperparathyroidism. (1975) (3)
- Persistent hyperparathyroidism caused by incomplete parathyroid resection and a hyperfunctioning parathyroid autograft. (1983) (3)
- Resistance to 1,25(OH)2D: Association with heterogeneous defects in cultured skin fibroblasts (1983) (3)
- Effects of Mutant Gene Dosage on Phenotype (2016) (2)
- 68 Gallium-DOTATATE PET/CT Scanning Results in Patients with MEN1 (2015) (2)
- 1200 MANIFESTATIONS OF 1,25-HYDROXYVITAMIN D RECEPTORS WITH ABNORMALLY LOW HORMONE AFFINITY: COMPARISON OF TWO KINDREDS (1985) (2)
- Menin Immunoreactivity in Secretory Granules of Human Pancreatic Islet Cells (2014) (2)
- Use of a highly polymorphic locus on human chromosome Hq13 discloses allelic loss in parathyroid tissues from uremic patients (1992) (2)
- High Total 68Ga-DOTATATE-Avid Tumor Volume (TV) is associated with low progression-free survival and high disease-specific mortality rate in patients with neuroendocrine tumors (2017) (2)
- Allelic Loss in Pituitary Tumors in Patients with Multiple Endocrine Neoplasia Syndrome Type 1 (2005) (2)
- Chapter 39 – Multiple Endocrine Neoplasia (2016) (1)
- 14th International workshop on multiple endocrine neoplasia and other rare endocrine tumors (2014) (1)
- Multiple Endocrine Neoplasia Type 1 : Clinical and Genetic Topics Moderator : (2009) (1)
- Low affinity of the receptor for 1 alpha,25-dihydroxyvitamin D3 in the marmoset, a New World monkey. (1985) (1)
- Hyperparathyroidism-Jaw Tumor Syndrome: Results of surgical management (2014) (1)
- Limited parathyroidectomy in multiple endocrine neoplasia type 1 associated primary hyperparathyroidism: a set up for failure (2014) (1)
- A VERY RAPID RECEPTOR MEDIATED ACTION OF 1,25-DIHYDROXYVITAMIN D3:INCREASE OF INTRACELLULAR CYCLIC GMP IN HUMAN SKIN FIBROBLASTS. (1988) (1)
- 1 , 25-Dihydroxyvitamin D 3 Receptors and Resistance : Implications in Rickets , Osteomalacia , and Other Conditions (2006) (1)
- Receptor-mediated rapid action of 1 a , 25-dihydroxycholecalciferol : Increase of intracellular cGMP in human skin fibroblasts ( steroid / signal transduction / nongenomic / calcium ) (2003) (1)
- Endocannabinoids as emerging suppressors of angiogenesis and breast tumor growth and metastatic spreading ” (2008) (1)
- Docetaxel in adjuvant therapy of breast cancer : results of the TAXIT 216 multicenter phase III trial ” (2008) (1)
- Hormonal regulation of cyclic 3',5'-AMP in specific recetor tissues. Biological effects of a synthetic N-terminal tetratriacontapeptide of parathyroid hormone. (1971) (1)
- Genetics of hyperparathyroidism (2000) (0)
- Chapter 58 – Multiple Endocrine Neoplasia Type 1 (2002) (0)
- Correction: Familial Hyperparathyroidism – Disorders of Growth and Secretion in Hormone-Secretory Tissue (2017) (0)
- Doctorate Program in Molecular Oncology and Endocrinology XVIII cycle-2002–2006 Coordinator: Prof. Giancarlo Vecchio “NOVEL MECHANISMS RESPONSIBLE FOR CONTROLLING GLUCOSE-INDUCED INSULIN SECRETION IN PANCREATIC BETA-CELLS” (2006) (0)
- Editorial: Imaging to detect early endocrine cancers. (2006) (0)
- INTERACTION BETWEEN THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR AND PDK 1 AS POTENTIAL THERAPEUTIC TARGET IN NEOPLASTIC CELLS ” (2007) (0)
- Doctorate Program in Molecular Oncology and Endocrinology (2006) (0)
- Parathyroid hormone and vitamin D receptors. (1983) (0)
- ArteriographicLocalizationof ParathyroidAdenomain the Presenceof LingualThyroid (1981) (0)
- Results of Reoperation for No. 6 Persistent and Recurrent Hyperpara thyroidism (1981) (0)
- Subject Index, Vol. 24, 1986 (1986) (0)
- MEN-1 gene mutation associated with a somatomammotroph macroadenoma in a 5-year-old boy: in vitro and in vivo studies of the tumor and response to therapy † 489 (1998) (0)
- Vitamin D-dependent Rickets Type 11 Defective Induction of 25-Hydroxyvitamin D3-24-Hydroxylase by 1,25-Dihydroxyvitamin D3 in Cultured Skin Fibroblasts (2013) (0)
- Heterogeneous coupling mechanisms between vitamin D receptors and their target actions (1990) (0)
- SUN-366 Neonatal Severe Hyperparathyroidism: Extreme Hypercalcemia as a Robust Marker for Homozygous Dosage of Pathogenic CASR Variants (2020) (0)
- Gefitinib and Radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck ” (2008) (0)
- Who Should Have Genetic Testing in Primary Hyperparathyroidism to Optimize Surgical Management (2017) (0)
- Exaggerated cyclic AMP response to parathyroid hormone in familial hypocalciuric hypercalcemia (1979) (0)
- Combined use of intravenous and oral calcium for treatment of vitamin D dependent rickets type II (VDDRII) (1992) (0)
- GeneThat CauseFamilial Hypocalciuric Hypercalcemia (1995) (0)
- Comparison of Vitamin D Receptor ( VDR ) Content by lmmunocytology with 9 A 7 Antibody and by Calcitriol High A ~ inity Binding Capacity from Competitive Binding Studies with [ zH ] Calcitriol in Various Cell Lines (2002) (0)
- Incidence of primary hyperparathyroidism. (1980) (0)
- Adenylate cyclase from kidney and bone. (1974) (0)
- Technetium-99m-SestamibiImaging before Reoperation for PrimaryHyperparathyroidism (1995) (0)
- Partnering and functioning of the MEN1 tumour suppressor gene (2004) (0)
- Molecular mechanisms of insulin resistance : role of endocannabinoid system in the regulation of glucose metabolism and insulin action ” (2007) (0)
- MINISYMPOSIUM MEN & VHL (1998) (0)
- Parathyroid tumors in familial multiple endocrine neoplasia type 1: The role of direct acting oncogenes and tumor suppressor genes (1990) (0)
- Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas (2006) (0)
- Erratum to J Intern Med 2004; 255: 692–730 (2004) (0)
- Subject Index Vol. 71, Suppl. 2, 2009 (2009) (0)
- Uncertainties in distinction of typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia. (1982) (0)
- Abstract 5646: Germline activating mutations in the proto-oncogeneGCM2in primary hyperparathyroidism (2017) (0)
- New genes involved in the neoplastic transformation of the thyroid gland (2006) (0)
- Denosumab-Induced Prolonged Hypocalcemia and Hypophosphatemia in Three Patients With Severe Primary Hyperparathyroidism and Renal Insufficiency (2014) (0)
- Gene expression profile analysis of pituitary adenomas developed by HMGA transgenic mice ” (2007) (0)
- Imaging to Detect Early Endocrine Cancers (2006) (0)
- Receptors and cyclic nucleotides in secretion and action of parathyroid hormone (1976) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stephen J. Marx?
Stephen J. Marx is affiliated with the following schools:
